On June 25, 2015, the Energy & Commerce Health Subcommittee will review three bipartisan bills that aim to improve health care for newborns, infants, and children. Specifically, members will discuss:

  • H.R. 2820, the Stem Cell Therapeutic and Research Reauthorization Act, to reauthorize programs that promote bone marrow, adult stem cell, and cord blood donations, match

Congressional committees have held several hearings on health policy issues since returning from August break. For instance, on September 15, the House Energy and Commerce Subcommittee on Health held a hearing on “Medicare’s Competitive Bidding Program for Durable Medical Equipment: Implications for Quality, Cost, and Access.” The Senate Appropriations Committee also met to examine

This post was written by Paul Sheives.

FDA recently released two guidance documents (one in draft form) concerning hematopoietic reconstitution for specified indications as hematopoietic progenitor cells, cord (HPC-C), which provide information to manufacturers seeking licensure and potential sponsors for Investigational New Drugs Applications (INDs). FDA announced that it no longer intends to exercise enforcement